ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $424 | -4.5% | 20,348 | +9.8% | 0.05% | -43.2% |
| Q2 2023 | $444 | +37.5% | 18,535 | +8.1% | 0.08% | +84.1% |
| Q1 2023 | $323 | -25.7% | 17,142 | -37.2% | 0.04% | -33.3% |
| Q4 2022 | $435 | -99.9% | 27,316 | +48.4% | 0.07% | +43.5% |
| Q3 2022 | $301,000 | -14.0% | 18,401 | -25.9% | 0.05% | -25.8% |
| Q2 2022 | $350,000 | -15.3% | 24,834 | +45.5% | 0.06% | -8.8% |
| Q1 2022 | $413,000 | -15.9% | 17,072 | -18.9% | 0.07% | -19.0% |
| Q4 2021 | $491,000 | +3.6% | 21,048 | -26.3% | 0.08% | +47.4% |
| Q3 2021 | $474,000 | -17.0% | 28,553 | +21.9% | 0.06% | -13.6% |
| Q2 2021 | $571,000 | -16.4% | 23,417 | -11.5% | 0.07% | -45.5% |
| Q1 2021 | $683,000 | -49.9% | 26,456 | +3.9% | 0.12% | -26.7% |
| Q4 2020 | $1,362,000 | – | 25,468 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |